Wisconsin Dermatological Society
SPRING Meeting
saturday, april 9, 2022
Agenda |
|
| 8:00 a.m. | Registration, Breakfast, and Sponsor Exhibits |
| 9:00 a.m. |
Welcome |
| 9:15 a.m. |
George T. Reizner, MD Lecture: Esther Freeman, MD COVID-19 & the Dermatologist: Variants, vaccines, and what's to come |
| 10:15 a.m. | Break and Pharmaceutical Exhibits |
| 10:45 a.m. |
Interesting Cases from UW Dermatology (see details below) |
| 11:30 a.m. | Chairman's Lecture: Robert Micheletti, MD |
| 12:30 p.m. | Lunch, Sponsor Exhibits, Poster Presentations, WDS Business Meeting, Resident Kodachrome Session |
| 1:45 p.m. |
Interesting Cases from UW Dermatology (see details below) |
| 2:15 p.m. |
UW Faculty Lecture: Charlotte LaSenna, MD |
| 2:45-3:45 p.m. | Reception and Packing "Blessings in a Backpack" donations |
| schedule is subject to change |
Presenters |
|
   |
Esther Freeman, MD PhD FAAD is Director of Global Health Dermatology at Massachusetts General Hospital and associate professor at Harvard Medical School. She has worked to improve healthcare, especially for those affected by HIV, in sub-Saharan Africa, Latin America, and southeast Asia since 2003. She has collaborated with the World Health Organization since 2011 to establish guidelines for the treatment of HIV-associated skin conditions in the developing world. She has continued her work on guidelines, and is immediate past chair of the Clinical Guidelines Committee for the AAD. She is founding chair of GLODERM, the International Alliance for Global Health Dermatology. Dr. Freeman is a member of the AAD's Ad Hoc Task Force on COVID-19, and is the principal investigator of the international COVID-19 Dermatology Registry, which is a collaboration between the AAD and the ILDS. She has authored numerous publications on COVID-19 dermatology and COVID-19 vaccines, and has been featured for her work on COVID-19 in the lay press in The New York Times, The Washington Post, and NPR, among others. She received a 2021 Presidential Citation from the American Academy of Dermatology for her work on COVID-19. |
  | Charlotte LaSenna, MD is an Assistant Professor of Dermatology at the University of Wisconsin-Madison. She completed Dermatology Residency and Dermatopathology Fellowship at the Cleveland Clinic. During her medical training at the University of Miami, Dr. LaSenna completed a year-long research fellowship with a special focus on both alopecia and dermatopathology. Her interest in the treatment of patients with hair loss continued to grow throughout her training. At the University of Wisconsin-Madison, Dr. LaSenna has created an Alopecia Specialty Clinic dedicated to the management of all forms of hair loss. |
  | Robert Micheletti, MD is a graduate of Stanford University and Duke University School of Medicine. He completed a combined residency in internal medicine and dermatology at the University of Pennsylvania, where he is now Associate Professor of Dermatology and Medicine. He is the Chief of Hospital Dermatology at Penn as well as Chief of Dermatology at Pennsylvania Hospital. He also directs the Cutaneous Vasculitis Clinic in the Penn Vasculitis Center. He has clinical and research focuses in vasculitis, severe drug reactions, autoimmune blistering diseases, hidradenitis suppurativa, and other areas of complex medical dermatology. He is the recipient of teaching awards from medical students and housestaff, and in 2019 he was elected to the Academy of Master Clinicians at Penn Medicine. |
UW Madison Resident Presenters
|
Details |
Venue
Sheraton Madison
706 John Nolen Drive
Madison, WI 53713
Virtual Options
Attend in real time via Zoom.
Participate remotely on Saturday, April 9th. CME and MOC will be available.
Watch the recording at your convenience.
Video of the meeting will be available through December 31, 2022. CME and MOC will not be available for any delayed viewing. No registration is necessary. We will send the link to all members in late April.
Cost
WDS Members: Free
Residents: Free
Non-Members: $100
No refunds will be given.
COVID Protocols
Face coverings are required for all attendees in meetings and events spaces at all times except when eating or speaking from the stage. Both the WDS and the venue are monitoring the recommendations of the CDC. We will inform registrants if there are any changes made.
Questions
Dana Kader Robb
WDS Administrator
Continuing Education
|
ACCME Accreditation StatementThe
activity has been planned and implemented in accordance with the
accreditation requirements and policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint providership of Wisconsin Medical Society and the Wisconsin Dermatological Society.
The Wisconsin Medical Society is accredited by the ACCME to provide
continuing medical education for physicians.
AMA Credit Designation Statement
The Wisconsin Medical Society designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience and Scope of Practice
This
program is intended for dermatologists, dermatopathologists,
dermatologic surgeons, nurse practitioners, physician assistants, WDS
members, and other allied healthcare providers who work with patients
that have dermatologic diseases. The secondary target audience is
dermatology residents.
Statement of Purpose
To
keep dermatology providers abreast of relevant new clinical knowledge
and dermatological skills, in order to provide quality medical care for
their patients, and improved healthcare outcomes.
The Wisconsin Dermatological Society fully intends to comply with the legal requirements of Title III of the Americans with Disabilities Act of 1990. If any participant of the conference is in need of accommodations, please call 414-750-4404.
CONTACT US   Wisconsin Dermatological Society |